Peter Salzmann - Net Worth and Insider Trading

Peter Salzmann Net Worth

The estimated net worth of Peter Salzmann is at least $28 Million dollars as of 2024-11-29. Peter Salzmann is the CEO of Immunovant Inc and owns about 978,097 shares of Immunovant Inc (IMVT) stock worth over $28 Million. Details can be seen in Peter Salzmann's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Peter Salzmann has not made any transactions after 2024-11-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Peter Salzmann

To

Peter Salzmann Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Peter Salzmann owns 3 companies in total, including Corbus Pharmaceuticals Holdings Inc (CRBP) , Immunovant Inc (IMVTU) , and Immunovant Inc (IMVT) .

Click here to see the complete history of Peter Salzmann’s form 4 insider trades.

Insider Ownership Summary of Peter Salzmann

Ticker Comapny Transaction Date Type of Owner
CRBP Corbus Pharmaceuticals Holdings Inc 2020-05-20 director
IMVTU Immunovant Inc 2020-05-15 director & Chief Executive Officer
IMVT Immunovant Inc 2024-11-20 director & Chief Executive Officer

Peter Salzmann Latest Holdings Summary

Peter Salzmann currently owns a total of 1 stock. Peter Salzmann owns 978,097 shares of Immunovant Inc (IMVT) as of November 20, 2024, with a value of $28 Million.

Latest Holdings of Peter Salzmann

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
IMVT Immunovant Inc 2024-11-20 978,097 28.73 28,100,727

Holding Weightings of Peter Salzmann


Peter Salzmann Form 4 Trading Tracker

According to the SEC Form 4 filings, Peter Salzmann has made a total of 28 transactions in Immunovant Inc (IMVT) over the past 5 years, including 0 buys and 28 sells. The most-recent trade in Immunovant Inc is the sale of 16,692 shares on November 20, 2024, which brought Peter Salzmann around $424,811.

Insider Trading History of Peter Salzmann

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Peter Salzmann Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Peter Salzmann Ownership Network

Ownership Network List of Peter Salzmann

No Data

Ownership Network Relation of Peter Salzmann

Insider Network Chart

Peter Salzmann Owned Company Details

What does Corbus Pharmaceuticals Holdings Inc do?

Who are the key executives at Corbus Pharmaceuticals Holdings Inc?

Peter Salzmann is the director of Corbus Pharmaceuticals Holdings Inc. Other key executives at Corbus Pharmaceuticals Holdings Inc include Chief Financial Officer Sean F. Moran , director & Chief Executive Officer Yuval Cohen , and Chief Commercial Officer Craig Stuart Millian .

Corbus Pharmaceuticals Holdings Inc (CRBP) Insider Trades Summary

Over the past 18 months, Peter Salzmann made no insider transaction in Corbus Pharmaceuticals Holdings Inc (CRBP). Other recent insider transactions involving Corbus Pharmaceuticals Holdings Inc (CRBP) include a net purchase of 1,032,632 shares made by Cormorant Global Healthcare Master Fund, Lp , a net purchase of 900,000 shares made by Cormorant Asset Management, Lp , and a net sale of 63,358 shares made by Yuval Cohen .

In summary, during the past 3 months, insiders sold 0 shares of Corbus Pharmaceuticals Holdings Inc (CRBP) in total and bought 350,000 shares, with a net purchase of 350,000 shares. During the past 18 months, 81,401 shares of Corbus Pharmaceuticals Holdings Inc (CRBP) were sold and 1,932,632 shares were bought by its insiders, resulting in a net purchase of 1,851,231 shares.

Corbus Pharmaceuticals Holdings Inc (CRBP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Corbus Pharmaceuticals Holdings Inc Insider Transactions

No Available Data

Peter Salzmann Mailing Address

Above is the net worth, insider trading, and ownership report for Peter Salzmann. You might contact Peter Salzmann via mailing address: 320 W 37th Street, 3rd Floor, New York Ny 10016.

Discussions on Peter Salzmann

No discussions yet.